237 related articles for article (PubMed ID: 15510595)
21. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
Cagle PT; Truong LD; Roggli VL; Greenberg SD
Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
[TBL] [Abstract][Full Text] [Related]
23. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases.
Ordóñez NG
Mod Pathol; 2006 Mar; 19(3):373-83. PubMed ID: 16400322
[TBL] [Abstract][Full Text] [Related]
24. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
25. Miliary pulmonary metastases from a clinically occult pleural mesothelioma.
Livasy CA; Tishko DJ; Maygarden SJ
Ann Diagn Pathol; 2003 Aug; 7(4):249-53. PubMed ID: 12913849
[TBL] [Abstract][Full Text] [Related]
26. Deciduoid pleural mesothelioma.
Monaghan H; Al-Nafussi A
Histopathology; 2001 Jul; 39(1):104-6. PubMed ID: 11454052
[No Abstract] [Full Text] [Related]
27. Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival.
Serio G; Scattone A; Pennella A; Giardina C; Musti M; Valente T; Pollice L
Histopathology; 2002 Apr; 40(4):348-52. PubMed ID: 11943019
[TBL] [Abstract][Full Text] [Related]
28. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
Padgett DM; Cathro HP; Wick MR; Mills SE
Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
[TBL] [Abstract][Full Text] [Related]
29. Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
Klebe S; Brownlee NA; Mahar A; Burchette JL; Sporn TA; Vollmer RT; Roggli VL
Mod Pathol; 2010 Mar; 23(3):470-9. PubMed ID: 20081811
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
Wei MC; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):559-564. PubMed ID: 28810297
[No Abstract] [Full Text] [Related]
31. Glycogen-rich mesothelioma.
Ordóñez NG; Mackay B
Ultrastruct Pathol; 1999; 23(6):401-6. PubMed ID: 10626691
[TBL] [Abstract][Full Text] [Related]
32. Pathology of diffuse malignant pleural mesothelioma.
Corson JM
Semin Thorac Cardiovasc Surg; 1997 Oct; 9(4):347-55. PubMed ID: 9352951
[TBL] [Abstract][Full Text] [Related]
33. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
Soini Y; Kinnula V; Kahlos K; Pääkkö P
J Clin Pathol; 2006 Mar; 59(3):250-4. PubMed ID: 16505274
[TBL] [Abstract][Full Text] [Related]
34. 'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff.
Attanoos RL; Gibbs AR
Histopathology; 2003 Nov; 43(5):444-52. PubMed ID: 14636270
[TBL] [Abstract][Full Text] [Related]
35. Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma.
Clover J; Oates J; Edwards C
Histopathology; 1997 Aug; 31(2):140-3. PubMed ID: 9279564
[TBL] [Abstract][Full Text] [Related]
36. Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma.
Granville LA; Younes M; Churg A; Roggli VL; Henderson DW; Cagle PT
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):75-9. PubMed ID: 15722797
[TBL] [Abstract][Full Text] [Related]
37. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
[TBL] [Abstract][Full Text] [Related]
38. Malignant sarcomatoid mesothelioma of the pleura: a histological and immunohistological study of a case.
Avellini C; Alampi G; Cocchi V; Sabattini E; Agosti R; Schiavina M; Pileri S; Piccaluga A
Pathologica; 1991; 83(1085):335-40. PubMed ID: 1923633
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma.
Leers MP; Aarts MM; Theunissen PH
Histopathology; 1998 Mar; 32(3):209-16. PubMed ID: 9568505
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
